Share Prices & Company Research

Stockbroking

C4x Discovery Holdings

Current Price 48.00p Bid 46.00p Ask 50.00p Change -3.03%
Last Updated: 19/07/2019 19:52. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

C4X Discovery Holdings plc aims to create the world's most productive drug discovery engine by using cutting-edge technologies and expertise to efficiently deliver best-in-class small-molecule medicines to clinical partners for the benefit of patients. The Company's business model focuses on replenishing big pharma discovery pipelines and driving returns through revenue generating pre-clinical licensing deals. In 2018, C4XD successfully out-licensed a pre-clinical programme in addictive disorders to Indivior in a deal worth up to $294m. C4XD has a state-of-the-art suite of proprietary technologies across the drug discovery process and accesses further innovative capabilities and expertise through its growing network of partners. The Company is actively advancing its diverse pre-clinical discovery portfolio which is focused on inflammation, neurodegeneration and oncology (including immuno-oncology).

Financial Highlights Year Ended 31/07/2018

Turnover
£7.06m
Operating Profit
£-2.53m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-20.29

Key Personnel

Clive James Dix
Chief Executive Officer
Bradley Richard Hoy
Chief Financial Officer
Dr Justian Craig Fox
Chief Scientific Officer
Eva-Lotta Allan
Non-Executive Chairman
Alexander James Stevenson
Non-Executive Director
Natalie Louise Walter
Non-Executive Director
Harry Finch
Non-Executive Director

Stock Details

EPIC
C4XD
ISIN
GB00BQQ2RV18
Shares in Issue
57,792,636
Market cap
£28.61m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
48.00p
Bid Price
46.00p
Ask Price
50.00p
Volume
81020
Change Today
-1.50p
% Change Today
-3.03%
Open
48.00p
Previous Close
48.00p
Intraday High
48.00p
Intraday Low
46.25p
52 Week High
112.50p
52 Week Low
45.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

C4x Discovery Holdings Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Tangible Assets
0.1
0.1
Intangible Assets & Goodwill
1.6
1.8
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
1.7
1.9
Inventory
0.0
0.0
Trade & Receivables
0.4
0.6
Cash & Receivables
5.6
6.0
Other Current Assets & Assets Held for Resale
1.4
1.7
Total Assets
9.0
10.1

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Short Term Liabilities
0.9
1.1
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
0.9
1.1

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Net Assets
8.2
9.1

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Share Capital
2.5
2.5
Minority Interests
0.0
0.0
Retained Earnings
-18.8
-17.7
Share Premium Account
22.8
22.8
Other Equity
1.6
1.4
Total Equity
8.2
9.1

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Cashflow from Operating Activities
-0.4
-6.6
Cashflow Before Financing
-0.5
-6.7
Increase / Decrease in Cash
-0.5
4.7

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Turnover
7.1
0.1
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.1
Operating Profit
-2.5
-8.5
Pre-Tax Profit
-2.5
-8.5
Profit / Loss for the Year
-1.1
-6.8
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.